Home
>
National Drug Code (NDC)
>
Urecholine
Urecholine - 51285-697-02 - (Bethanechol Chloride)
Drug Information of Urecholine
| Product NDC: | 51285-697 |
| Proprietary Name: | Urecholine |
| Non Proprietary Name: | Bethanechol Chloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; Bethanechol Chloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Urecholine
| Product NDC: | 51285-697 |
| Labeler Name: | Teva Women's Health, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089095 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20010201 |
Package Information of Urecholine
| Package NDC: | 51285-697-02 |
| Package Description: | 100 TABLET in 1 BOTTLE (51285-697-02) |
NDC Information of Urecholine
| NDC Code | 51285-697-02 |
| Proprietary Name | Urecholine |
| Package Description | 100 TABLET in 1 BOTTLE (51285-697-02) |
| Product NDC | 51285-697 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bethanechol Chloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20010201 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Women's Health, Inc. |
| Substance Name | BETHANECHOL CHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Agonist [EPC],Cholinergic Muscarinic Agonists [MoA] |
